Antipsychotic-treated patients with schizophrenia see benefits from semaglutide, study claims

A multicenter collaboration of Danish researchers reports that once-weekly semaglutide for 30 weeks lowered blood sugar levels and body weight and improved physical quality of life in antipsychotic-treated adults with schizophrenia and prediabetes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup